Emerging RNA editing biomarkers will foster drug development.
Sign Up to like & getrecommendations! Published in 2017 at "Drug discovery today"
DOI: 10.1016/j.drudis.2017.01.017
Abstract: Unanticipated adverse drug reactions (ADRs) on the central nervous system are a major cause of clinical attrition and market withdrawal. Current practices for their prospective assessment still lean on extensive analysis of rodent behaviour despite… read more here.
Keywords: emerging rna; foster drug; biomarkers foster; drug ... See more keywords